Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma(legacy) | 90 |
| Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma(legacy) | 82 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma | 9 | 3 | 4 | 2 | 4 | 4 | 4 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 69 |
| Australia | 13 |
| France | 9 |
| Netherlands | 8 |
| Vietnam | 8 |
| Germany | 5 |
| China | 3 |
| Singapore | 3 |
| Iran | 1 |
| Qatar | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 24 |
| Fairfield | 11 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Canberra | 6 |
| Kaleen | 5 |
| Cambridge | 3 |
| Boardman | 2 |
| Des Moines | 2 |
| Seattle | 2 |